------------------------------
OMB APPROVAL
------------------------------
OMB NUMBER: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per form .......14.90
------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Gliatech, Inc.
-------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01
-------------------------------------------------------------
(Title of Class of Securities)
37929C103
-------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with the statement [ ]. (A fee is
not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five-percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percept or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SEC 1745 (2/95) Page 1 of 9
<PAGE>
13G
CUSIP No. 37929C103 Page 2 of 9 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Montgomery Medical Ventures II, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES 0
BENEFICIALLY -----------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON -----------------------------------------------------------
WITH
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*See instructions Before Filling Out!
<PAGE>
13G
CUSIP No. 37929C103 Page 3 of 9 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Montgomery Medical Partners II, L.P.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES 0
BENEFICIALLY -----------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON -----------------------------------------------------------
WITH
7 SOLE DISPOSITIVE POWER
0
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.0%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
*See instructions Before Filling Out!
<PAGE>
13G
CUSIP No. 37929C103 Page 4 of 9 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jack Olshansky
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES 940
BENEFICIALLY -----------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON -----------------------------------------------------------
WITH
7 SOLE DISPOSITIVE POWER
940
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
940
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*See instructions Before Filling Out!
<PAGE>
13G
CUSIP No. 37929C103 Page 5 of 9 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven N. Weiss
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES 403
BENEFICIALLY -----------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH
REPORTING 0
PERSON -----------------------------------------------------------
WITH
7 SOLE DISPOSITIVE POWER
403
-----------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
403
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES* [ ]
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 1%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*See instructions Before Filling Out!
<PAGE>
Page 6
Of 9
Item 1.
- --------------------------------------------------------------------------------
(a) Name of Issuer
Gliatech, Inc.
- --------------------------------------------------------------------------------
(b) Address of Issuer's Principal Executive Offices
23420 Commerce Park Road, Cleveland, OH 44122
- --------------------------------------------------------------------------------
Item 2.
- --------------------------------------------------------------------------------
(a) Name of Person(s) Filing
Entities: Montgomery Medical Ventures II, L.P. ("MMVII")
Montgomery Medical Partners II, L.P. ("MMPII")
Individual: Jack Olshansky, General Partner of MMPII ("JO")
Steven N. Weiss, General Partner of MMPII ("SW")
- --------------------------------------------------------------------------------
(b) Address of Principal Business Office or, if None, Residence:
505 Sansome Street, 14th Floor, San Francisco, CA 94111
- --------------------------------------------------------------------------------
(c) Citizenship
Entities: MMVII; California
MMPII; California
Individuals: JO; United States of America
SW; United States of America
- --------------------------------------------------------------------------------
(d) Title of Class of Securities
Common Stock, $.01 par value per share
- --------------------------------------------------------------------------------
(e) CUSIP Number
37929C103
- --------------------------------------------------------------------------------
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check
whether the person filing is a: NOT APPLICABLE
- --------------------------------------------------------------------------------
(a) [ ] Broker or Dealer registered under Section 15 of the Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of the act
(d) [ ] Investment Company registered under section 8 of the Investment
Company Act
(e) [ ] Investment Adviser registered under section 203 of the Investment
Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of 1974
or Endowment Fund; see ss. 240.13d-1(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with ss.240.13d-1(b)(ii)(G)
(Note: See Item 7)
(h) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(H)
- --------------------------------------------------------------------------------
<PAGE>
Page 7
Of 9
Item 4. Ownership
If the percent of the class owned, as of December 31 of the year covered by
the statement, or as of the last day of any month described in Rule
13d-1(b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a
right to acquire.
- --------------------------------------------------------------------------------
ENTITIES: MMVII MMPII
-------------- --------------
(a) Amount Beneficially Owned
0 0
- --------------------------------------------------------------------------------
(b) Percent of Class
0.0% 0.0%
- --------------------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote
or to direct the vote 0 0
- --------------------------------------------------------------------------------
(ii) Shared power to vote
or to direct the vote 0 0
- --------------------------------------------------------------------------------
(iii) Sole power to dispose
or to direct the disposition of 0 0
- --------------------------------------------------------------------------------
(iv) Shared power to dispose or
to direct the disposition of 0 0
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
INDIVIDUALS: Olshansky Weiss
-------------- --------------
(a) Amount Beneficially Owned
940 403
- --------------------------------------------------------------------------------
(b) Percent of Class
Less than 1% Less than 1%
- --------------------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote
or to direct the vote 940 403
- --------------------------------------------------------------------------------
(ii) Shared power to vote
or to direct the vote 0 0
- --------------------------------------------------------------------------------
(iii) Sole power to dispose
or to direct the disposition of 940 403
- --------------------------------------------------------------------------------
(iv) Shared power to dispose or
to direct the disposition of 0 0
- --------------------------------------------------------------------------------
Item 5. Ownership of Five Percent or Less of a Class
- --------------------------------------------------------------------------------
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [X].
- --------------------------------------------------------------------------------
Item 6. Ownership of More than Five Percent on Behalf of Another Person
- --------------------------------------------------------------------------------
NOT APPLICABLE
- --------------------------------------------------------------------------------
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
- --------------------------------------------------------------------------------
NOT APPLICABLE
- --------------------------------------------------------------------------------
<PAGE>
Page 8
Of 9
Item 8. Identification and Classification of Members of the Group
- --------------------------------------------------------------------------------
NOT APPLICABLE
- --------------------------------------------------------------------------------
Item 9. Notice of Dissolution of Group
- --------------------------------------------------------------------------------
NOT APPLICABLE
- --------------------------------------------------------------------------------
Item 10. Certification (The following certification shall be included if
the statement is filed pursuant to Rule
13d-1(b):)
By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose of and do not have the effect of changing
or influencing the control of the issuer of such securities and were not
acquired in connection with or as a participant in any transaction having such
purposes or effect.
Exhibit A: Joint Filing Statement
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date 1/22/97
---------------------
Montgomery Medical Ventures II, L.P. /s/ Steven N. Weiss
By: Montgomery Medical Partners II, L.P. ------------------------------------
By: Steven N. Weiss, General Partner
Montgomery Medical Partners II, L.P. /s/ Steven N. Weiss
By: Steven N. Weiss, General Partner ------------------------------------
Jack Olshansky /s/ Jack Olshansky
------------------------------------
Steven N. Weiss /s/ Steven N. Weiss
------------------------------------
<PAGE>
Page 9
Of 9
Exhibit A
JOINT FILING STATEMENT
Pursuant to Rule 13d-1(f)(1), we, the undersigned, hereby express our agreement
that the attached Schedule 13G is filed on behalf of each of us.
Dated: January 22, 1997
-----------------
Montgomery Medical Ventures II, L.P.
By: Montgomery Medical Partners II, L.P.
By: /s/ Steven N. Weiss
--------------------------------------
Steven N. Weiss
General Partner
Montgomery Medical Partners II, L.P.
By: /s/ Steven N. Weiss
--------------------------------------
Steven N. Weiss
General Partner
/s/ Jack Olshansky
-----------------------------------------
Jack Olshansky
/s/ Steven N. Weiss
-----------------------------------------
Steven N. Weiss
